164 related articles for article (PubMed ID: 1707604)
21. Transient expression of human immunodeficiency virus type 1 genome results in a nonproductive infection in human fetal dorsal root ganglia glial cells.
Kunsch C; Wigdahl B
Virology; 1989 Dec; 173(2):715-22. PubMed ID: 2512746
[TBL] [Abstract][Full Text] [Related]
22. Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle.
Shirazi Y; Pitha PM
J Virol; 1992 Mar; 66(3):1321-8. PubMed ID: 1738192
[TBL] [Abstract][Full Text] [Related]
23. Suppressive effects of interferons on the production and release of human T-lymphotropic virus type-I (HTLV-I).
Oka T; Ohtsuki Y; Sonobe H; Furihata M; Miyoshi I
Arch Virol; 1990; 115(1-2):63-73. PubMed ID: 1701080
[TBL] [Abstract][Full Text] [Related]
24. AZT (zidovudine) may act postintegrationally to inhibit generation of HIV-1 progeny virus in chronically infected cells.
Rooke R; Tremblay M; Wainberg MA
Virology; 1990 May; 176(1):205-15. PubMed ID: 1691885
[TBL] [Abstract][Full Text] [Related]
25. In vitro assays show a dissociation of reverse transcriptase activity and core antigen (p24) production in two HIV-1 isolates from a patient receiving long-term treatment with zidovudine (ZDV).
Masquelier B; Combeau T; Poveda JD; Delord B; Pellegrin JL; Sallafranque-Andreola ML; Tarrago-Litvak L; Fleury HJ
J Acquir Immune Defic Syndr (1988); 1991; 4(5):499-505. PubMed ID: 1707962
[TBL] [Abstract][Full Text] [Related]
26. Effect of cloned human interferons on protein synthesis and morphogenesis of herpes simplex virus.
Chatterjee S; Hunter E; Whitley R
J Virol; 1985 Nov; 56(2):419-25. PubMed ID: 2997465
[TBL] [Abstract][Full Text] [Related]
27. Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines.
Brack-Werner R; Kleinschmidt A; Ludvigsen A; Mellert W; Neumann M; Herrmann R; Khim MC; Burny A; Müller-Lantzsch N; Stavrou D
AIDS; 1992 Mar; 6(3):273-85. PubMed ID: 1373627
[TBL] [Abstract][Full Text] [Related]
28. Regulation of HIV replication in infected monocytes by IFN-alpha. Mechanisms for viral restriction.
Gendelman HE; Baca LM; Turpin J; Kalter DC; Hansen B; Orenstein JM; Dieffenbach CW; Friedman RM; Meltzer MS
J Immunol; 1990 Oct; 145(8):2669-76. PubMed ID: 1976701
[TBL] [Abstract][Full Text] [Related]
29. The ratio of defective HIV-1 particles to replication-competent infectious virions.
Bourinbaiar AS
Acta Virol; 1994 Feb; 38(1):59-61. PubMed ID: 7520666
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues.
Meek TD; Lambert DM; Dreyer GB; Carr TJ; Tomaszek TA; Moore ML; Strickler JE; Debouck C; Hyland LJ; Matthews TJ
Nature; 1990 Jan; 343(6253):90-2. PubMed ID: 1688646
[TBL] [Abstract][Full Text] [Related]
31. The morphogenesis of a Chinese strain of HIV-1 forming inclusion bodies in Jurkat-tat III cells.
Li QG; Zhang YJ; Liang Y; Feng CQ; Li YZ; Sjöberg R; Jiang Y; Wang NF; Wadell G
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun; 9(2):103-13. PubMed ID: 7749785
[TBL] [Abstract][Full Text] [Related]
32. Interferon alpha-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells.
Shirazi Y; Pitha PM
Virology; 1993 Mar; 193(1):303-12. PubMed ID: 8438572
[TBL] [Abstract][Full Text] [Related]
33. Potent anti-feline immunodeficiency virus and anti-human immunodeficiency virus effect of IFN-tau.
Pontzer CH; Yamamoto JK; Bazer FW; Ott TL; Johnson HM
J Immunol; 1997 May; 158(9):4351-7. PubMed ID: 9126998
[TBL] [Abstract][Full Text] [Related]
34. Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments.
Kaplan AH; Swanstrom R
Proc Natl Acad Sci U S A; 1991 May; 88(10):4528-32. PubMed ID: 2034693
[TBL] [Abstract][Full Text] [Related]
35. Specific inhibition of viral protein synthesis in HIV-infected cells in response to interferon treatment.
Coccia EM; Krust B; Hovanessian AG
J Biol Chem; 1994 Sep; 269(37):23087-94. PubMed ID: 7521875
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 gag proteins in virions and in infected cell fractions.
Sharova NK; Grigor'ev VB; Bukrinskaya AG
Biomed Sci; 1991; 2(3):279-84. PubMed ID: 1751761
[TBL] [Abstract][Full Text] [Related]
37. Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS).
Krown SE; Gold JW; Niedzwiecki D; Bundow D; Flomenberg N; Gansbacher B; Brew BJ
Ann Intern Med; 1990 Jun; 112(11):812-21. PubMed ID: 1971504
[TBL] [Abstract][Full Text] [Related]
38. Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.
Sei S; Yang QE; O'Neill D; Yoshimura K; Nagashima K; Mitsuya H
J Virol; 2000 May; 74(10):4621-33. PubMed ID: 10775598
[TBL] [Abstract][Full Text] [Related]
39. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.
Yang OO; Kalams SA; Rosenzweig M; Trocha A; Jones N; Koziel M; Walker BD; Johnson RP
J Virol; 1996 Sep; 70(9):5799-806. PubMed ID: 8709196
[TBL] [Abstract][Full Text] [Related]
40. Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by 1-[(2-hydroxyethoxy)methyl]-6-phenylthiothymine (HEPT) and recombinant alpha interferon.
Ito M; Baba M; Shigeta S; De Clercq E; Walker RT; Tanaka H; Miyasaka T
Antiviral Res; 1991 May; 15(4):323-30. PubMed ID: 1683214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
